αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinoma

Abstract Nasopharyngeal carcinoma (NPC) remains a highly aggressive malignancy with poor outcomes in advanced and recurrent disease. Although immune checkpoint inhibitors combined with chemotherapy improve survival, many patients still experience relapse or disease progression. Here, we developed a...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Kwanpirom Suwanchiwasiri, Chalermchai Somboonpatarakun, Nan Chaiyariti, Utid Suriya, Surang Chankhamhaengdecha, Pa‑thai Yenchitsomanus, Tavan Janvilisri, Mutita Junking
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer 2026-05-01
סדרה:	Cancer Immunology, Immunotherapy
נושאים:	Bispecific protein engager Bispecific protein engager-armed T cells Cancer immunotherapy Trop2 Nasopharyngeal carcinoma
גישה מקוונת:	https://doi.org/10.1007/s00262-026-04406-y
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!